Trial Profile
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2024
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Hyperalgesia; Pain
- Focus Therapeutic Use
- 02 Jan 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 13 Mar 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 04 Apr 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.